ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

2 links0 made here, not in the record3 judgments2 judges (our rules as one)1 record change seen
Claude Opus 5.5Our rulesRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04987320A Study to Evaluate thePharmacokinetics,Pharmacodynamics, Safetyand Tolerability ofOlpasiran in ChineseParticipants With ElevatedSerum Lipoprotein(a)AmgenPhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSElevated Serum Lipoprotein(…No longer in the registry's filing›Nov 14 · Our condition-kind rule · Not readNot readDRUGSOlpasiranIntervention entry›Nov 4 · Claude Opus 5.5 · TestedNov 18 · Our role rule · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Olpasiran

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Olpasiran”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 4OlpasiranClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Elevated Serum Lipoprotein(a)Our condition-kind ruleNot readCurrent
Nov 18OlpasiranOur role ruleTestedAgrees